IP Library › Granted Patent US 12,209,892
Granted Patent B1
US 12,209,892 · App. 18/900,208 · Granted Jan 28, 2025

Method and apparatus for breath-hold monitoring in diagnostic and therapeutic procedures

Inventor: Manojeet Bhattacharya (Edina, MN)
Assignee: EmpNia Inc.
G01D5/35316A41D13/1281A61B5/6804G01D5/35335G01D5/35367G01L1/246G02B6/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,209,892
App. No.
18/900,208
Filed
Sep 27, 2024
Granted
Jan 28, 2025
Kind
B1
Art Unit
2874
USPC
385/13
Abstract

A method for compensating for dynamic changes in a body of a patient during a controlled interaction with the body includes acquiring data from at least one sensing device disposed on the body and detecting a change along at least one optical fiber of the sensing device caused by dynamic changes associated with the body during the controlled interaction. A respiratory gating signal is generated based on the change along the at least one optical fiber of the sensing device measured over time. The method further comprises controlling relative movement between the body and an interactive device in response to the respiratory gating signal to compensate for the dynamic changes associated with the body during the controlled interaction.

Claims (54)

1. A method of compensating for dynamic changes in a body of a patient during a controlled interaction with the body, the method comprising:

acquiring data from a sensing device disposed on the body;

detecting a change along at least one optical fiber of the sensing device caused by dynamic changes associated with the body during the controlled interaction;

generating a respiratory gating signal based on the change along the at least one optical fiber of the sensing device measured over time; and

controlling relative movement between the body and an interactive device in response to the respiratory gating signal to compensate for the dynamic changes associated with the body during the controlled interaction.

2. The method of claim 1 , wherein the sensing device comprises at least one fiber Bragg grating (FBG).

3. The method of claim 2 , wherein:

the acquiring data from the sensing device comprises acquiring wavelength data from the at least one FBG;

the detecting the change along the at least one optical fiber comprises detecting effective shifts of Bragg wavelengths in the wavelength data; and

the generating the respiratory gating signal comprises generating the respiratory gating signal based on the effective shifts of the Bragg wavelengths.

4. The method of claim 1 , wherein the dynamic changes associated with the body include at least one of body deformation, respiratory motion, tumor motion, or organ motion.

5. The method of claim 1 , further comprising:

pausing the controlled interaction when the respiratory gating signal indicates at least one of a release of a voluntary breath hold, a voluntary excursion associated with the voluntary breath hold, or an involuntary excursion associated with the voluntary breath hold.

6. The method of claim 1 , wherein the respiratory gating signal is associated with at least one of a Respiratory Deep Inspiration Breath Hold or an Expiration Breath Hold.

7. The method of claim 1 , wherein the controlled interaction is at least one of an image acquisition, an external beam treatment, a focused energy treatment procedure, a biopsy procedure, or a guided placement of an interventional device.

8. The method of claim 7 , wherein the external beam treatment is external beam radiotherapy or proton beam therapy.

9. A method of compensating for dynamic changes in a body of a patient during a controlled interaction with the body, the method comprising:

acquiring wavelength data from at least one fiber Bragg grating (FBG) disposed on a body;

detecting effective shifts of Bragg wavelengths in the wavelength data caused by dynamic changes associated with the body during the controlled interaction;

generating a respiratory gating signal based on the effective shifts of the Bragg wavelengths measured over time; and

controlling an interactive device, based on the respiratory gating signal, to pause the controlled interaction during the dynamic changes associated with the body.

10. The method of claim 9 , wherein the dynamic changes associated with the body include at least one of body deformation, respiratory motion, tumor motion, or organ motion.

11. The method of claim 9 , wherein the respiratory gating signal is associated with a voluntary breath hold, the controlling the interactive device comprises controlling the interactive device when the respiratory gating signal indicates at least one of a release of the voluntary breath hold, a voluntary excursion associated with the voluntary breath hold, or an involuntary excursion associated with the voluntary breath hold.

12. The method of claim 9 , wherein the respiratory gating signal is associated with at least one of a Respiratory Deep Inspiration Breath Hold or an Expiration Breath Hold.

13. The method of claim 9 , wherein the controlled interaction is at least one of image acquisition or a therapeutic interaction.

14. The method of claim 9 , wherein the controlled interaction is a therapeutic interaction, the therapeutic interaction including at least one of an external beam treatment, a focused energy treatment procedure, a biopsy procedure, or a guided placement of an interventional device.

15. The method of claim 14 , wherein the external beam treatment is external beam radiotherapy or proton beam therapy.

16. A method of compensating for dynamic changes in a body of a patient during a controlled interaction with the body, the method comprising:

acquiring wavelength data from at least one fiber Bragg grating (FBG) disposed on a body;

detecting effective shifts of Bragg wavelengths in the wavelength data caused by dynamic changes associated with the body during the controlled interaction;

generating a respiratory gating signal based on the effective shifts of the Bragg wavelengths measured over time; and

controlling a scanning device based on the respiratory gating signal such that image data is not acquired during the dynamic changes associated with the body.

17. The method of claim 16 , wherein the dynamic changes associated with the body include at least one of body deformation, respiratory motion, tumor motion, or organ motion.

18. The method of claim 16 , wherein the respiratory gating signal indicates a voluntary breath hold.

19. The method of claim 18 , further comprising:

pausing the controlled interaction when the respiratory gating signal indicates at least one of a release of the voluntary breath hold, a voluntary excursion associated with the voluntary breath hold, or an involuntary excursion associated with the voluntary breath hold.

20. The method of claim 16 , further comprising:

controlling an interactive device based at least in part on the acquired image data to perform the controlled interaction with the body while compensating for the dynamic changes.

21. The method of claim 16 , wherein the respiratory gating signal is associated with at least one of a Respiratory Deep Inspiration Breath Hold or an Expiration Breath Hold.

22. The method of claim 16 , wherein the controlled interaction is a therapeutic interaction, the therapeutic interaction including at least one of an external beam treatment, a focused energy treatment procedure, a biopsy procedure, or a guided placement of an interventional device.

23. The method of claim 22 , wherein the external beam treatment is external beam radiotherapy or proton beam therapy.

24. A method of compensating for dynamic changes in a body of a patient during a controlled interaction with the body, the method comprising:

acquiring wavelength data from at least one fiber Bragg gratings (FBG) disposed on a body;

detecting effective shifts of Bragg wavelengths in the wavelength data caused by dynamic changes associated with the body during the controlled interaction;

generating a respiratory gating signal based on the effective shifts of the Bragg wavelengths measured over time;

controlling a scanning device, based at least in part on the respiratory gating signal, to acquire image data of a target region of the body while compensating for the dynamic changes associated with the body; and

controlling an interactive device, based at least in part on the respiratory gating signal and the acquired image data, to perform the controlled interaction with the target region.

25. The method of claim 24 , wherein the dynamic changes associated with the body include at least one of body deformation, respiratory motion, tumor motion, or organ motion.

26. The method of claim 24 , wherein the respiratory gating signal indicates a voluntary breath hold.

27. The method of claim 26 , further comprising:

pausing the controlled interaction when the respiratory gating signal indicates at least one of a release of the voluntary breath hold, a voluntary excursion associated with the voluntary breath hold, or an involuntary excursion associated with the voluntary breath hold.

28. The method of claim 24 , wherein the respiratory gating signal is associated with at least one of a Respiratory Deep Inspiration Breath Hold or an Expiration Breath Hold.

29. The method of claim 24 , wherein the controlled interaction is a therapeutic interaction, the therapeutic interaction including at least one of an external beam treatment, a focused energy treatment procedure, a biopsy procedure, or a guided placement of an interventional device.

30. The method of claim 29 , wherein the external beam treatment is external beam radiotherapy or proton beam therapy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2024
From: BHATTACHARYA, MANOJEET
To: EMPNIA INC.
Reel/Frame 069036/0704 →
Continuity (4)
Continuation In Part 18409081 · Jan 10, 2024
Continuation 17224855 · Apr 7, 2021
Continuation In Part PCTUS2020065691 · Dec 17, 2020
Continuation In Part 16723352 · Dec 20, 2019
References Cited (92)
US 4868381A · Davis · 1989 [cited by applicant]
US 4909260A · Salem et al. · 1990 [cited by applicant]
US 5545993A · Taguchi et al. · 1996 [cited by applicant]
US 5907403A · Andrews et al. · 1999 [cited by applicant]
US 6475153B1 · Khair et al. · 2002 [cited by applicant]
US 7077810B2 · Lange et al. · 2006 [cited by applicant]
US 7257436B2 · Sasaki et al. · 2007 [cited by applicant]
US 7678063B2 · Felmlee et al. · 2010 [cited by applicant]
US 8553959B2 · Hsieh et al. · 2013 [cited by applicant]
US 8655441B2 · Fletcher et al. · 2014 [cited by applicant]
US 9088130B2 · Kim et al. · 2015 [cited by applicant]
US 9116055B2 · Johnston · 2015 [cited by examiner]
US 9304018B2 · Davis · 2016 [cited by examiner]
US 9730654B2 · Erbel et al. · 2017 [cited by applicant]
US 9841331B2 · Wood · 2017 [cited by examiner]
US 9987503B2 · Grass · 2018 [cited by examiner]
US 10234934B2 · Connor · 2019 [cited by examiner]
US 10321873B2 · Connor · 2019 [cited by examiner]
US 10332644B2 · Garcia · 2019 [cited by applicant]
US 10488916B2 · Hahami · 2019 [cited by examiner]
US 10524701B2 · Kim · 2020 [cited by examiner]
US 10716510B2 · Connor · 2020 [cited by examiner]
US 11041740B1 · Bhattacharya · 2021 [cited by applicant]
US 11504010B2 · Bhattacharya · 2022 [cited by applicant]
US 20080045813A1 · Phuah et al. · 2008 [cited by applicant]
US 20080146947A1 · Kojima et al. · 2008 [cited by applicant]
US 20090185772A1 · Xia et al. · 2009 [cited by applicant]
US 20090234240A1 · Kuenzler et al. · 2009 [cited by applicant]
US 20130035587A1 · Lagendijk et al. · 2013 [cited by applicant]
US 20130211261A1 · Wang et al. · 2013 [cited by applicant]
US 20140064332A1 · Johnston · 2014 [cited by examiner]
US 20140088377A1 · Manzke · 2014 [cited by examiner]
US 20140128721A1 · Forthmann · 2014 [cited by examiner]
US 20140238153A1 · Wood · 2014 [cited by examiner]
US 20140268099A1 · Moslehi · 2014 [cited by applicant]
US 20150124266A1 · Davis · 2015 [cited by examiner]
US 20150359455A1 · Hahami · 2015 [cited by examiner]
US 20150359467A1 · Tran · 2015 [cited by applicant]
US 20160202755A1 · Connor · 2016 [cited by examiner]
US 20160256710A1 · Goldstein et al. · 2016 [cited by applicant]
US 20160338644A1 · Connor · 2016 [cited by examiner]
US 20160361194A1 · Hautvast · 2016 [cited by examiner]
US 20170007849A1 · Hautvast · 2017 [cited by examiner]
US 20170049341A1 · Karabacak et al. · 2017 [cited by applicant]
US 20170354353A1 · Kim · 2017 [cited by examiner]
US 20180008196A1 · Connor · 2018 [cited by examiner]
US 20180364115A1 · Brown · 2018 [cited by examiner]
US 20190298265A1 · Keating et al. · 2019 [cited by applicant]
US 20190336038A1 · Gorgutsa · 2019 [cited by examiner]
US 20210186340A1 · Bhattacharya · 2021 [cited by applicant]
US 20210190549A1 · Bhattacharya · 2021 [cited by applicant]
US 20210223068A1 · Bhattacharya · 2021 [cited by applicant]
US 20230070912A1 · Bhattacharya · 2023 [cited by applicant]
US 20240032816A1 · Bhattacharya · 2024 [cited by applicant]
US 20240210218A1 · Bhattacharya · 2024 [cited by applicant]
CN 111317481A · 2020 [cited by applicant]
JP H0775627A · 1995 [cited by applicant]
JP 2014525764A · 2014 [cited by applicant]
JP 2015231512A · 2015 [cited by applicant]
JP 2017506543A · 2017 [cited by applicant]
JP 2017506555A · 2017 [cited by applicant]
JP 2017519221A · 2017 [cited by applicant]
WO WO2012168836A2 · 2012 [cited by applicant]
WO WO2013180085A1 · 2013 [cited by applicant]
WO WO2015128179A1 · 2015 [cited by applicant]
WO WO2015128392A1 · 2015 [cited by applicant]
WO WO2015167340A1 · 2015 [cited by applicant]
WO WO2016147795A1 · 2016 [cited by applicant]
WO WO2017037479A1 · 2017 [cited by applicant]
WO WO2017190085A1 · 2017 [cited by applicant]
WO WO2019031041A1 · 2019 [cited by applicant]
WO WO2021127207A1 · 2021 [cited by applicant]
WO WO2021127233A1 · 2021 [cited by applicant]
WO WO2022020519A1 · 2022 [cited by applicant]
ZA 200508066B · 2007 [cited by applicant]
Anzai Medical, Co., Ltd, “Respiratory Gating System AZ-733V1: What is a Respiratory Gating System,” http://www.anzai-med.co.jp, No. date given, 4 pages. [cited by applicant]
Davies, Justine et al., “Beyond Blood Pressure: Pulse Wave Analysis—a Better Way of Assessing Cardiovascular Risk?” Future Cardiology, pp. 69-78, (2005). [cited by applicant]
De Jonckheere, J., et al.; “Ofseth: A breathing motions monitoring system for patients under MRI,” 32nd Annual International Conference of the IEEE EMBS, 2010, 1016-1019. [cited by applicant]
Esper, Stephen A. et al., “Arterial Waveform Analysis,” Best Practice & Research Clinical Anaesthesiology 28 pp. 363-380, (2014). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/065691, mailed Jun. 1, 2021, 25 pages. [cited by applicant]
Invitation to Pay Additional Fees for PCT Application No. PCT/US2020/065691, dated Apr. 9, 2021, 20 pages. [cited by applicant]
Katsuragawa Yui, et al., “Non-invasive Blood Pressure Measurement by Pulse Wave Analysis Using FBG Sensor,” 2015 IEEE International Instrumentation and Measurement Technology Conference (12MTC) Proceedings, IEEE, May 11… [cited by applicant]
Khan, Yasser et al., “A Flexible Organic Reflectance Oximeter Array”, Proceedings of the National Academy of Sciences 115 (47), pages E11015-E11024; Washington, DC, Nov. 2018. [cited by applicant]
Lau, Doreen, et al. “Intensity-Modulated Microbend Fiber Optic Sensor for Respiratory Monitoring and Gating During MRI,” IEEE Transactions on Biomedical Engineering, vol. 60, No. 9, Sep. 2013, pp. 2655-2662. [cited by applicant]
Lee, Hooseok et al., “Reflectance Pulse Oximetry: Practical Issues and Limitation,” The Korean Institute of Communications and Information Services, ScienceDirect, 195-198 Nov. 2016. [cited by applicant]
Lui, J. et al., “Evaluation of the combined use of two different respiratory monitoring systems for 4D CtTsimulation and gated treatment,” Journal of Applied Clinical Medical Physics, Wiley 19:5 pp. 666-675, (2018). [cited by applicant]
Niekic, Paula “Pulse Contour Cardiac Output (PiCCO) Learning Package,” Liverpool Hospital Intensive Care Unit, Feb. 29, 2016, 17 pages. [cited by applicant]
Office Action for Japanese Application No. 2023-130280, mailed Sep. 17, 2024, with English translation, 9 pages. [cited by applicant]
Office Action for Japanese Application No. JP20220538314 with English translation, dated May 1, 2023, 8 pages. [cited by applicant]
Office Action for Japanese Application No. JP20220538314 with English translation, dated Nov. 7, 2023, 10 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/723,352, dated Nov. 24, 2020, 9 pages. [cited by applicant]
Roylance, David, “Stress-Strain Curves, Department of Materials Science and Engineering,” Massachusetts Institute of Technology, Cambridge, MA, Aug. 23, 2001, 14 pages. [cited by applicant]
Cited By (2)
US 12,516,964 US 12,605,078